Thank you for your interest in covering the 2025 Association for Molecular Pathology (AMP) Annual Meeting & Expo, which will be held Nov. 11–15, 2025, at the Boston Convention Center and Exhibition Center.
This five-day event features more than 200 exhibiting companies, 60 informative educational sessions, and more than 500 poster presentations.
AMP’s more than 3,100 members practice in various disciplines of molecular diagnostics, including bioinformatics, infectious diseases, inherited conditions and oncology.
Registered members of the media gain access to cutting-edge lectures, corporate-sponsored workshops and plenary sessions focusing on major areas of clinical molecular diagnostics.
We hope that you find this year's meeting to be both informative and enjoyable.
We offer complimentary registration for writers and editors at print, online and broadcast news media outlets. Qualifying journalists will receive:
Applicants must provide their media credentials and/or a letter of assignment to register and must bring qualifying identification upon arrival.
Contact Andrew Noble at anoble@amp.org or 415-722-2129 for more information.
Learn about our credentialing requirements, photography/videography policies, press room resources and more.
The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP’s 3,100+ members practice various disciplines of molecular diagnostics, including bioinformatics, infectious diseases, inherited conditions, and oncology. They are pathologists, clinical laboratory directors, basic and translational scientists, technologists, and trainees who practice in a variety of settings, including academic and community medical centers, government, and industry.
AMP is the primary resource for expertise, education and collaboration in one of the fastest-growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high-quality, appropriate testing.
For more information, visit www.amp.org.